Nephros (NEPH) EBITDA Margin Growth (5y) (2015 - 2026)
Nephros (NEPH) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,945.00 |
| Mar 31, 2026 | 3,907.00 |
| Dec 31, 2025 | 3,119.00 |
| Sep 30, 2025 | 5,053.00 |
| Jun 30, 2025 | 10,694.00 |
| Mar 31, 2025 | 5,217.00 |
| Dec 31, 2024 | 1,740.00 |
| Sep 30, 2024 | 2,831.00 |
| Jun 30, 2024 | 2,784.00 |
| Mar 31, 2024 | 6,787.00 |
| Dec 31, 2023 | 2,528.00 |
| Sep 30, 2023 | 2,422.00 |
| Jun 30, 2023 | 3,553.00 |
| Mar 31, 2023 | 10,573.00 |
| Dec 31, 2022 | 391.00 |
| Sep 30, 2022 | 337.00 |
| Jun 30, 2022 | 5,293.00 |
| Mar 31, 2022 | 1,077.00 |
| Dec 31, 2021 | 6,194.00 |
| Sep 30, 2021 | 12,540.00 |